- Bruker Completes Acquisition of Molecular Diagnostics Innovator ELITech
- Bruker Reports First Quarter 2024 Financial Results
- Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference
- Bruker Announces Date and Time of First Quarter 2024 Earnings Release and Webcast
- Bruker to Acquire the NanoString Business in an Asset Deal
- Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies
- Bruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates
- Bruker Selected as ‘Company of the Year’ by Instrument Business Outlook
- Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO
- Bruker Announces Closing of Chemspeed Technologies AG Acquisition
More ▼
Key statistics
On Friday, Bruker Corp (BRKR:NSQ) closed at 70.05, 30.22% above the 52 week low of 53.79 set on Oct 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 70.71 |
---|---|
High | 71.97 |
Low | 69.70 |
Bid | 67.76 |
Offer | 74.65 |
Previous close | 70.09 |
Average volume | 1.34m |
---|---|
Shares outstanding | 145.33m |
Free float | 97.12m |
P/E (TTM) | 24.09 |
Market cap | 10.18bn USD |
EPS (TTM) | 2.91 USD |
Annual div (ADY) | 0.20 USD |
---|---|
Annual div yield (ADY) | 0.29% |
Div ex-date | Feb 29 2024 |
Div pay-date | Mar 15 2024 |
Data delayed at least 15 minutes, as of May 03 2024 21:00 BST.
More ▼